Treace Medical Concepts Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Treace Medical Concepts Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Florida
- Headquarters city
- Ponte Vedra
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TMCI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001630627
- EIN
- 47-1052611
Board of directors
-
Betsy Hanna · DirectorSince 2023
-
Deepti Jain · DirectorSince 2023
-
F. Barry Bays · DirectorSince 2023
-
James T. Treace · DirectorSince 2023
-
Jane E. Kiernan · DirectorSince 2023
-
John K. Bakewell · DirectorSince 2023
-
John T. Treace · Director · Chief Executive OfficerSince 2023
-
Lance A. Berry · DirectorSince 2023
-
Lawrence W. Hamilton · DirectorSince 2023
-
Richard W. Mott · DirectorSince 2023
-
Thomas E. Timbie · DirectorSince 2023
Chief executives
John T. Treace
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.0%
-
97.6%
Board connections
1 of this board's directors also sit on 2 other boards.
- via John K. Bakewell
- via John K. Bakewell
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,351,455
- 12 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 24, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +11,000 | $4.34 | $47,731 |
| Aug 21, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +5,000 | $4.35 | $21,748 |
| Aug 20, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +39,944 | $4.44 | $177,176 |
| Aug 9, 2026 | Elder Scot Michael Officer (Chief Legl & Comp Off, CorpSec) | Shares withheld for tax | −16,253 | — | — |
| Aug 9, 2026 | Hair Mark Officer (Chief Financial Officer) | Shares withheld for tax | −37,102 | — | — |
| Aug 9, 2026 | Scanlan Sean F. Officer (Chief Innovation Officer) | Shares withheld for tax | −9,814 | — | — |
| Jun 11, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +22,887 | $4.04 | $92,463 |
| Jun 10, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +29,430 | $4.02 | $118,309 |
| Jun 1, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +50,000 | $3.56 | $178,000 |
| May 28, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +61,202 | $3.02 | $184,830 |
| May 27, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +49,810 | $2.87 | $142,955 |
| May 26, 2026 | John T. Treace Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +4,508 | $2.79 | $12,577 |
| May 19, 2026 | John K. Bakewell Director | Grant or award | +30,000 | — | — |
| May 19, 2026 | Jane E. Kiernan Director | Grant or award | +30,000 | — | — |
| May 19, 2026 | Deepti Jain Director | Grant or award | +30,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.